The FINA Anti-Doping Commission has heard the case of Russian breaststroker Yulia Efimova, and is now verifying facts and reflecting upon arguments ahead of a hearing in the matter, according to Russian media.
Efimova tested positive in October of 2013 for the banned substance DHEA, and would go on to break the FINA World Record in the 200 short course meter breaststroke en route to a European Short Course Championship in December. A few weeks prior, in November, she also broke the short course meters World Record in the 50 breaststroke, and she also took European titles in the 50 breaststroke, the 200 medley relay, and the 200 mixed medley relay after her positive test.
“At the meeting of Yuliya Efimova came together with a lawyer from the United States, where she trains,” said Russian Federation chief Vladimir Salnikov in Russian. “The hearing was also attended by a representative of the Russian side with an interpreter. The meeting lasted almost the whole day, but as I was said, the decision will be announced later.”
Efimova trains with the Trojan Swim Club in Southern California, and several eye witnesses report that she has continued to train there during her temporary suspension, which FINA issued on January 24th.
Any appeals of the decision of the FINA Doping Panel would be heard in front of the Court of Arbitration for Sport (CAS) in Switzerland.